Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 5 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 20 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - water for injections, quantity: 10 ml - injection, solution - excipient ingredients: - water for injections bp is used to dissolve or dilute substances or preparations for parenteral administration. ,water for injections bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) - solution for infusion - 10 mg/ml - active: gentamicin sulfate 10 mg/ml (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) excipient: disodium edetate dihydrate sodium hydroxide sulfuric acid water for injection - dbl™ gentamicin injection bp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa proteus species (indole positive and indole negative) escherichia coli klebsiella - enterobacter - serratia species staphylococcus species (coagulase positive and coagulase negative) dbl™ gentamicin injection bp should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia respiratory tract infections infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis urinary tract infections (recurrent, complicated) dbl™ gentamicin injection bp is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. dbl™ gentamicin injection bp may be considered as initial therapy in suspected or confirmed gram negative infections and therapy may be instituted before obtained results of susceptibility testing. if anaerobic organisms are suspected, additional antimicrobial therapy should be added to the gentamicin regime.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gentamicin sulfate 16mg (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) - solution for injection - 10 mg/ml - active: gentamicin sulfate 16mg (gentamicin sulfate 16mg/ml (bp) equivalent to 10mg/ml (10,000iu) gentamicin) excipient: disodium edetate dihydrate sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate water for injection - dbl™ gentamicin injection bp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa proteus species (indole positive and indole negative) escherichia coli klebsiella - enterobacter - serratia species staphylococcus species (coagulase positive and coagulase negative) dbl™ gentamicin injection bp should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia respiratory tract infections infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis urinary tract infections (recurrent, complicated) dbl™ gentamicin injection bp is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. dbl™ gentamicin injection bp may be considered as initial therapy in suspected or confirmed gram negative infections and therapy may be instituted before obtained results of susceptibility testing. if anaerobic organisms are suspected, additional antimicrobial therapy should be added to the gentamicin regime.

New Zealand - English - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - gentamicin sulfate 65mg (gentamicin sulfate 65 mg/ml (bp) equivalent to 40mg/ml (40,000iu) gentamicin); gentamicin sulfate 65mg (gentamicin sulfate 65 mg/ml (bp) equivalent to 40mg/ml (40,000iu) gentamicin) - solution for injection - 40 mg/ml - active: gentamicin sulfate 65mg (gentamicin sulfate 65 mg/ml (bp) equivalent to 40mg/ml (40,000iu) gentamicin) excipient: disodium edetate dihydrate sodium hydroxide sulfuric acid water for injection active: gentamicin sulfate 65mg (gentamicin sulfate 65 mg/ml (bp) equivalent to 40mg/ml (40,000iu) gentamicin) excipient: disodium edetate dihydrate sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate water for injection - dbl™ gentamicin injection bp is indicated in the treatment of serious infections caused by susceptible strains of the following microorganisms: pseudomonas aeruginosa proteus species (indole positive and indole negative) escherichia coli klebsiella - enterobacter - serratia species staphylococcus species (coagulase positive and coagulase negative) dbl™ gentamicin injection bp should be considered for the treatment of the following conditions when caused by susceptible organisms: septicaemia respiratory tract infections infected wounds, bone and soft tissue infections including peritonitis, septic abortion and burns complicated by sepsis urinary tract infections (recurrent, complicated) dbl™ gentamicin injection bp is not routinely indicated in the initial treatment of uncomplicated urinary tract infections unless the organism is resistant to other less toxic antibacterials. dbl™ gentamicin injection bp may be considered as initial therapy in suspected or confirmed gram negative infections and therapy may be instituted before obtained results of susceptibility testing. if anaerobic organisms are suspected, additional antimicrobial therapy should be added to the gentamicin regime.

Kenya - English - Pharmacy and Poisons Board

rusan pharma ltd. 58 / d, govt. industrial estate, charkop, - paracetamol bp …. 500 mg, codeine phosphate bp …… - tablet - paracetamol bp …. 500 mg, codeine phosphate bp …… - codeine combinations excl. psycholeptics

Kenya - English - Pharmacy and Poisons Board

rainbow life sciences private limited 5th floor, plot 2, sector 19d, vashi, navi, - "1 mg/ml (domperidone bp) 4 mg/ml (simeticone bp)… - oral drops, suspension - "1 mg/ml (domperidone bp) 4 mg/ml (simeticone bp)… - other drugs for drugs for bile therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - hyoscine hydrobromide, quantity: 400 microgram/ml - injection, solution - excipient ingredients: water for injections - hyoscine injection bp is indicated as a pre-operative medication to produce sedation and amnesia. it is also used pre-operatively to inhibit salivation and excessive secretions of the respiratory tract. hyoscine hydrobromide is also indicated for the treatment of selected cases of nausea and vomiting resulting from motion sickness, although oral or transdermal administration is more frequently used for this indication.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - water for injection 100%{vol} - solution for injection - active: water for injection 100%{vol} - water for injection bp is used to dissolve or dilute substances or preparations for parenteral administration. water for injection bp may also be used as an irrigating solution for small wounds or during minor surgical procedures.